Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Treasury Shares (2022 - 2025)

Candel Therapeutics' Treasury Shares history spans 2 years, with the latest figure at $448000.0 for Q4 2023.

  • On a quarterly basis, Treasury Shares changed 0.0% to $448000.0 in Q4 2023 year-over-year; TTM through Dec 2023 was $448000.0, a 0.0% change, with the full-year FY2023 number at $448000.0, changed 0.0% from a year prior.
  • Treasury Shares hit $448000.0 in Q4 2023 for Candel Therapeutics, roughly flat from $448000.0 in the prior quarter.
  • Over the last five years, Treasury Shares for CADL hit a ceiling of $612366.0 in Q4 2022 and a floor of -$122608.0 in Q4 2023.